Literature DB >> 16553609

S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK.

Nathalie Rouach1, Alice Pébay, William Même, Jocelyne Cordier, Pascal Ezan, Eric Etienne, Christian Giaume, Martine Tencé.   

Abstract

Sphingosine-1-phosphate (S1P) is a potent and pleiotropic bioactive lysophospholipid mostly released by activated platelets that acts on its target cells through its own G protein-coupled receptors. We have previously reported that mouse striatal astrocytes expressed mRNAs for S1P1 and S1P3 receptors and proliferate in response to S1P. Here, we investigated the effect of S1P on gap junctions. We show that a short-term exposure of astrocytes to S1P causes a robust inhibition of gap junctional communication, as demonstrated by dye coupling experiments and double voltage-clamp recordings of junctional currents. The inhibitory effect of S1P on dye coupling involves the activation of both Gi and Rho GTPases. Rho-associated kinase (ROCK) also plays a critical role. The capacity of S1P to activate a Rho/ROCK axis in astrocytes is demonstrated by the typical remodeling of actin cytoskeleton. Connexin43, the protein forming gap junction channels, is a target of the Gi- and Rho/ROCK-mediated signaling cascades. Indeed, as shown by Western blots and confocal immunofluorescence, its nonphosphorylated form increases following S1P treatment and this change does not occur when both cascades are disrupted. This novel effect of S1P may have an important physiopathological significance when considering the proposed roles for astrocyte gap junctions on neuronal survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16553609     DOI: 10.1111/j.1460-9568.2006.04671.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  31 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 2.  [Oral fingolimod in multiple sclerosis: therapeutic modulation of the sphingosine-1-phosphate system].

Authors:  O Aktas; J Ingwersen; B Kieseier; P Küry; R Hohlfeld; H-P Hartung
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

Review 3.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

Review 4.  Neuron-astroglial interactions in cell-fate commitment and maturation in the central nervous system.

Authors:  Joice Stipursky; Tânia Cristina Leite de Sampaio E Spohr; Vivian Oliveira Sousa; Flávia Carvalho Alcantara Gomes
Journal:  Neurochem Res       Date:  2012-05-22       Impact factor: 3.996

5.  Cellular expression profile of RhoA in rats with spinal cord injury.

Authors:  Wen-Jie Wei; Zhi-Yuan Yu; Huai-Jie Yang; Min-Jie Xie; Wei Wang; Xiang Luo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

6.  Chemerin-induced arterial contraction is Gi- and calcium-dependent.

Authors:  David J Ferland; Emma S Darios; Richard R Neubig; Benita Sjögren; Nguyen Truong; Rosa Torres; Thomas S Dexheimer; Janice M Thompson; Stephanie W Watts
Journal:  Vascul Pharmacol       Date:  2016-11-24       Impact factor: 5.773

7.  Pathway specific modulation of S1P1 receptor signalling in rat and human astrocytes.

Authors:  Luke M Healy; Graham K Sheridan; Adam J Pritchard; Aleksandra Rutkowska; Florian Mullershausen; Kumlesh K Dev
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

8.  RhoA GTPase and F-actin dynamically regulate the permeability of Cx43-made channels in rat cardiac myocytes.

Authors:  Mickaël Derangeon; Nicolas Bourmeyster; Isabelle Plaisance; Caroline Pinet-Charvet; Qian Chen; Fabien Duthe; Michel R Popoff; Denis Sarrouilhe; Jean-Claude Hervé
Journal:  J Biol Chem       Date:  2008-07-29       Impact factor: 5.157

9.  A role for connexin43 in macrophage phagocytosis and host survival after bacterial peritoneal infection.

Authors:  Rahul J Anand; Shipan Dai; Steven C Gribar; Ward Richardson; Jeff W Kohler; Rosemary A Hoffman; Maria F Branca; Jun Li; Xiao-Hua Shi; Chhinder P Sodhi; David J Hackam
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 10.  Regulation of human glia by multiple sclerosis disease modifying therapies.

Authors:  Luke M Healy; Mackenzie A Michell-Robinson; Jack P Antel
Journal:  Semin Immunopathol       Date:  2015-08-11       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.